This article has been cited by
1
Derek G. Waller,Anthony P. Sampson
.2018;()581
[DOI]
2Vancomycin in the treatment of methicillin-resistantStaphylococcus aureus– a clinician’s guide to the science informing current practice
Jean YH Lee,Benjamin P Howden
Expert Review of Anti-infective Therapy.2015;13(7)855
[DOI]
3ANTIBIYOTIKLERIN HÜCRE IÇI FARMAKOKINETIK ÖZELLIKLERI
Yasar SAHIN,Ebru YILDIRIM
Kirikkale Üniversitesi Tip Fakültesi Dergisi.2020;13(7)855
[DOI]
4Case Report: Artificial Elevation of Prothrombin Time by Telavancin
Derek F. Amanatullah,Matthew J. Lopez,Robert C. Gosselin,Munish C. Gupta
Clinical Orthopaedics & Related Research.2013;471(1)332
[DOI]
5Nosocomial Pneumonia in the Era of Multidrug-Resistance: Updates in Diagnosis and Management
Elena Xu,David Pérez-Torres,Paraskevi C. Fragkou,Jean-Ralph Zahar,Despoina Koulenti
Microorganisms.2021;9(3)534
[DOI]
6Methicillin-resistant Staphylococcus aureus : An update on the epidemiology, treatment options and infection control
Samar S. Boswihi,Edet E. Udo
Current Medicine Research and Practice.2018;8(1)18
[DOI]
7Synthesis of a pyrrolidine derivative of a carvotacetone and monoterpenes for anti-methicillin-resistant Staphylococcus aureus and anti-cryptococcal properties
Veronica M. Masila,Albert J. Ndakala,Jacob O. Midiwo,Robert Byamukama,Rahab W. Kamau,Mallika Kumarihamy,Ilias Muhammad
Natural Product Research.2020;8(1)1
[DOI]
8Synthesis of a pyrrolidine derivative of a carvotacetone and monoterpenes for anti-methicillin-resistant Staphylococcus aureus and anti-cryptococcal properties
Sulejman Alihodžic,Mirjana Bukvic,Ivaylo J. Elenkov,Antun Hutinec,Sanja Koštrun,Dijana Pešic,Gordon Saxty,Linda Tomaškovic,Dinko Žiher
Natural Product Research.2018;57(1)113
[DOI]
9Synthesis of a pyrrolidine derivative of a carvotacetone and monoterpenes for anti-methicillin-resistant Staphylococcus aureus and anti-cryptococcal properties
Taylor Hori,Yaw B. Owusu,Dianqing Sun
Natural Product Research.2021;57(1)113
[DOI]
10Microbial Resistance Movements: An Overview of Global Public Health Threats Posed by Antimicrobial Resistance, and How Best to Counter
Sameer Dhingra,Nor Azlina A. Rahman,Ed Peile,Motiur Rahman,Massimo Sartelli,Mohamed Azmi Hassali,Tariqul Islam,Salequl Islam,Mainul Haque
Frontiers in Public Health.2020;8(1)113
[DOI]
11Microbial Resistance Movements: An Overview of Global Public Health Threats Posed by Antimicrobial Resistance, and How Best to Counter
Stefano Biondi,Elena Chugunova,Mauro Panunzio
Frontiers in Public Health.2016;50(1)249
[DOI]
12Abundance, diversity and mobility potential of antibiotic resistance genes in pristine Tibetan Plateau soil as revealed by soil metagenomics
Bo Li,Zeng Chen,Fan Zhang,Yongqin Liu,Tao Yan
FEMS Microbiology Ecology.2020;96(10)249
[DOI]
13Vancomycin-Resistant Enterococcal Bacteremia Pharmacotherapy
Ruchi Patel,Jason C. Gallagher
Annals of Pharmacotherapy.2015;49(1)69
[DOI]
14Synthesis and biological evaluation of lipophilic teicoplanin pseudoaglycon derivatives containing a substituted triazole function
Zsolt Szucs,Magdolna Csávás,Erzsébet Roth,Anikó Borbás,Gyula Batta,Florent Perret,Eszter Ostorházi,Réka Szatmári,Evelien Vanderlinden,Lieve Naesens,Pál Herczegh
The Journal of Antibiotics.2017;70(2)152
[DOI]
15Peptide based antimicrobials: Design strategies and therapeutic potential
Prakash Kishore Hazam,Ruchika Goyal,Vibin Ramakrishnan
Progress in Biophysics and Molecular Biology.2019;142(2)10
[DOI]
16Breakthroughs in bacterial resistance mechanisms and the potential ways to combat them
Bahman Khameneh,Roudayna Diab,Kiarash Ghazvini,Bibi Sedigheh Fazly Bazzaz
Microbial Pathogenesis.2016;95(2)32
[DOI]
17Combinations of (lipo)glycopeptides with ß-lactams against MRSA: susceptibility insights
Razieh Kebriaei,Seth A Rice,Nivedita B Singh,Kyle C Stamper,Logan Nguyen,Zain Sheikh,Michael J Rybak
Journal of Antimicrobial Chemotherapy.2020;75(10)2894
[DOI]
  Feedback 
  Subscribe